Cargando…

Treatment of Morbihan disease

Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging....

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, Joo Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cleft Palate-Craniofacial Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257449/
https://www.ncbi.nlm.nih.gov/pubmed/34225403
http://dx.doi.org/10.7181/acfs.2021.00185
_version_ 1783718316081152000
author Kim, Joo Hyoung
author_facet Kim, Joo Hyoung
author_sort Kim, Joo Hyoung
collection PubMed
description Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging. MD often tends to be unresponsive to therapies commonly used to treat rosacea, including corticosteroids, isotretinoin, and antibiotics. Surgical treatments have therefore been attempted, but most cases showed unsatisfactory responses. These problems could have resulted from an incorrect recognition and interpretation of the pathophysiology of MD and inaccurate planning of the operation, resulting in recurrence or exacerbation of edema.
format Online
Article
Text
id pubmed-8257449
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Cleft Palate-Craniofacial Association
record_format MEDLINE/PubMed
spelling pubmed-82574492021-07-19 Treatment of Morbihan disease Kim, Joo Hyoung Arch Craniofac Surg Review Article Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging. MD often tends to be unresponsive to therapies commonly used to treat rosacea, including corticosteroids, isotretinoin, and antibiotics. Surgical treatments have therefore been attempted, but most cases showed unsatisfactory responses. These problems could have resulted from an incorrect recognition and interpretation of the pathophysiology of MD and inaccurate planning of the operation, resulting in recurrence or exacerbation of edema. Korean Cleft Palate-Craniofacial Association 2021-06 2021-06-25 /pmc/articles/PMC8257449/ /pubmed/34225403 http://dx.doi.org/10.7181/acfs.2021.00185 Text en Copyright © 2021 The Korean Cleft Palate-Craniofacial Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kim, Joo Hyoung
Treatment of Morbihan disease
title Treatment of Morbihan disease
title_full Treatment of Morbihan disease
title_fullStr Treatment of Morbihan disease
title_full_unstemmed Treatment of Morbihan disease
title_short Treatment of Morbihan disease
title_sort treatment of morbihan disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257449/
https://www.ncbi.nlm.nih.gov/pubmed/34225403
http://dx.doi.org/10.7181/acfs.2021.00185
work_keys_str_mv AT kimjoohyoung treatmentofmorbihandisease